Edwards Lifesciences Corp (EW)
89.14
-0.97
(-1.08%)
USD |
NYSE |
May 17, 16:00
89.15
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Cash from Operations (Quarterly): -53.50M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -53.50M |
December 31, 2023 | 136.60M |
September 30, 2023 | 411.50M |
June 30, 2023 | 33.60M |
March 31, 2023 | 314.10M |
December 31, 2022 | 282.80M |
September 30, 2022 | 309.90M |
June 30, 2022 | 332.20M |
March 31, 2022 | 293.30M |
December 31, 2021 | 373.60M |
September 30, 2021 | 531.90M |
June 30, 2021 | 526.10M |
March 31, 2021 | 300.50M |
December 31, 2020 | 399.80M |
September 30, 2020 | 216.10M |
June 30, 2020 | 231.30M |
March 31, 2020 | 207.10M |
December 31, 2019 | 402.90M |
September 30, 2019 | 437.30M |
June 30, 2019 | 341.20M |
March 31, 2019 | 1.50M |
December 31, 2018 | 292.90M |
September 30, 2018 | 342.30M |
June 30, 2018 | 140.20M |
March 31, 2018 | 151.30M |
Date | Value |
---|---|
December 31, 2017 | 363.90M |
September 30, 2017 | 310.80M |
June 30, 2017 | 197.70M |
March 31, 2017 | 128.30M |
December 31, 2016 | 201.10M |
September 30, 2016 | 205.90M |
June 30, 2016 | 190.30M |
March 31, 2016 | 107.10M |
December 31, 2015 | 103.80M |
September 30, 2015 | 202.50M |
June 30, 2015 | 170.10M |
March 31, 2015 | 73.30M |
December 31, 2014 | 93.20M |
September 30, 2014 | 12.20M |
June 30, 2014 | 778.00M |
March 31, 2014 | 138.90M |
December 31, 2013 | 111.30M |
September 30, 2013 | 132.20M |
June 30, 2013 | 128.10M |
March 31, 2013 | 101.10M |
December 31, 2012 | 114.70M |
September 30, 2012 | 131.30M |
June 30, 2012 | 146.80M |
March 31, 2012 | -30.70M |
December 31, 2011 | 93.40M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-53.50M
Minimum
Mar 2024
531.90M
Maximum
Sep 2021
301.42M
Average
312.00M
Median
Cash from Operations (Quarterly) Benchmarks
Stryker Corp | 204.00M |
Align Technology Inc | 28.66M |
Abbott Laboratories | 1.025B |
Boston Scientific Corp | 164.00M |
Steris PLC | 254.81M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 63.10M |
Cash from Financing (Quarterly) | 61.70M |
Free Cash Flow | 251.20M |
Free Cash Flow Per Share (Quarterly) | -0.2298 |
Free Cash Flow to Equity (Quarterly) | -139.00M |
Free Cash Flow to Firm (Quarterly) | -138.80M |
Free Cash Flow Yield | 0.46% |